Linical (2183) investor relations material

Executive summary

• Revenue for FY ended March 2026 declined 17% year-over-year to 8,665 million yen, mainly due to delays in major projects in the US and Europe.

• Operating loss widened to 2,073 million yen, and net loss attributable to owners of parent increased to 3,329 million yen, impacted by impairment losses on goodwill and fixed assets.

• Overseas business accounted for 59% of net sales and 53% of employees, reflecting a strong global presence.

• Order backlog as of May 22, 2026, increased 10.9% year-over-year to 13 billion yen, indicating future revenue potential.

• Comprehensive loss reached 2,915 million yen, compared to 642 million yen in the prior year.

Financial highlights

• Net sales dropped from 10,437 million yen in FY2025 to 8,665 million yen in FY2026.

• Gross profit dropped to 1,123 million yen from 2,375 million yen year-over-year.

• Operating income shifted from a profit of 583 million yen to a loss of 2,073 million yen.

• Net profit fell from 539 million yen to a loss of 3,329 million yen, reflecting significant impairment charges.

• Cost of sales ratio increased from 77.2% to 87.0% year-over-year.

Outlook and guidance

• FY ending March 2027 forecasts net sales of 10,680 million yen, a 23.2% increase year-over-year.

• Operating profit is projected to recover to 256 million yen, with net profit forecast at 180 million yen and net income per share at 7.97 yen.

• Dividend per share is planned to remain at 8 yen.

• Recovery in the US and Europe and growth in Asia are expected to drive the return to profitability.